You are here

AstraZeneca

FDA approves expanded indication for AstraZeneca's blood thinner

Yahoo/Reuters

Thu, 09/3/15 - 06:31 pm

AstraZeneca backs $80M round for ADC's antibody warhead tech

Fierce Biotech

Wed, 09/2/15 - 10:14 am

ADC Therapeutics

antibody-drug conjugate

AstraZeneca sales team revving up for new Brilinta marketing push

Fierce Pharma Marketing

Tue, 09/1/15 - 06:44 pm

AstraZeneca auctions off troubled psoriasis drug to Valeant in $445M deal

Fierce Biotech

Tue, 09/1/15 - 09:55 am

Valeant Pharmaceuticals

AstraZeneca’s Profitability for 2Q15

Yahoo/Market Realist

Sat, 08/29/15 - 08:58 am

FDA warns of severe joint pain risk with DPP-4 diabetes drugs

Yahoo/Reuters

Fri, 08/28/15 - 05:52 pm

DPP-4 inhibitor

Boehringer Ingelheim

AstraZeneca’s Oncology Segment: How Did It Perform in 2Q15?

Yahoo/Market Realist

Fri, 08/28/15 - 08:12 am

AstraZeneca uses snails and overstuffed luggage to push OIC awareness--and its branded solution

Fierce Pharma Marketing

Thu, 08/27/15 - 09:24 am

opiod-induced constipation

AstraZeneca’s CVMD Segment: How Did It Perform in 2Q15?

Yahoo/Market Realist

Wed, 08/26/15 - 10:43 am

cardiovascular disease

metabolic disorders

AstraZeneca Oncology Partnerships To Help Recover Sales

Bidness ETC

Tue, 08/25/15 - 09:43 am

Peregrine Pharmaceuticals

Heptares Therapeutics

Mirati Therapeutics

Juno Therapeutics

AstraZeneca lures Sean Bohen from Genentech to fill top R&D post

Fierce Biotech

Mon, 08/24/15 - 11:25 am

Lilly, Sanofi, Novo among many pharma players to throw off big price gains in H1

Fierce Pharma

Sat, 08/22/15 - 08:48 am

Forget Inovio's Q2 Results -- All Eyes Are Focused on These 3 Developments

Motley Fool

Thu, 08/20/15 - 02:49 pm

Stalwart brands from AZ, Glaxo and Sanofi top ranks of most-prescribed meds

Fierce Pharma

Mon, 08/17/15 - 11:41 am

Things To Consider About AstraZeneca's Partnership With Inovio

Seeking Alpha

Wed, 08/12/15 - 09:02 am

AstraZeneca bags another cancer drug deal, this time with Inovio

Yahoo/Reuters

Mon, 08/10/15 - 07:59 am

cancer immunotherapy

AstraZeneca plc (ADR) Strikes 2 Immuno-Oncology Deals; Are Its Efforts In The Right Direction?

Bidness, ETC

Fri, 08/7/15 - 10:56 am

immuno-oncology

Heptares Therapeutics

Mirati Therapeutics

Value of AstraZeneca's immuno-oncology deal could top $500M

Bizjournals.com

Thu, 08/6/15 - 12:14 pm

immuno-oncology

Heptares Therapeutics

China gets tougher for Western drugmakers

Yahoo/Reuters

Thu, 08/6/15 - 10:27 am

AstraZeneca ties up with little Mirati on another PD-L1 combo trial

Fierce Biotech

Thu, 08/6/15 - 08:27 am

PD-1 inhibitors

Mirati Therapeutics

Pages